Ultrasound-Guided INTRAPEC Injection for Breast Surgery: A Novel Solution for Surgical Field Improvement During Electrocautery and Implantation and for Postoperative Pain and Muscle Spasm Reduction for Breast Surgery
This article introduces a novel ultrasound-guided injection called the INTRAPEC technique as a solution to the specific problem of intraoperative pectoral major muscle spasm during electrocautery and manipulation. The technique is a cost-effective, nonparenteral method for improving the surgical field during pectoral major isolation and subsequent implant placement. The technique may have added benefits such as a significant reduction in surgical complexity causing trauma and bleeding and significant reductions in postoperative pain and muscle spasm.
2. Govshievich A, Kirkham K, Brull R, Brown MH. Novel approach to intractable pectoralis major muscle spasms following submuscular expander-implant breast reconstruction. Plast Surg Case Studies. 2015;1(3):68-70.
3. Shin HJ, Shin JC, Kim WS, Chang WH, Lee SC. Application of ultrasound-guided trigger point injection for myofascial trigger points in the subscapularis and pectoralis muscles to post-mastectomy patients: a pilot study. Yonsei Med J. 2014;55(3):792-799. https://doi.org/10.3349/ymj.2014.55.3.792
4. Leiman D, Barlow M, Carpin K, Piña EM, Casso D. Medial and lateral pectoral nerve block with liposomal bupivacaine for the management of postsurgical pain after submuscular breast augmentation. Plast Reconstr Surg Glob Open. 2014;2(12):e282. https://doi.org/10.1097/GOX.0000000000000253
5. Trignano E, Dessy LA, Fallico N, et al. Treatment of pectoralis major flap myospasms with botulinum toxin type A in head and neck reconstruction. J Plast Reconstr Aesthet Surg. 2012;65(2):e23-e28. https://doi.org/10.1016/j.bjps.2011.10.002
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors agree to the Creative Commons License listed below, which can be viewed by clicking the link below.
This work will be licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.